Conference item icon

Conference item

CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL

Publication status:
Published

Actions


Authors


Expand authors...
Volume:
23
Pages:
181-182
Host title:
ANNALS OF ONCOLOGY
Publication date:
2012-09-01
ISSN:
0923-7534
Source identifiers:
364260
Pubs id:
pubs:364260
UUID:
uuid:dca8e578-1bad-41f6-8c91-e10930a0cc60
Local pid:
pubs:364260
Deposit date:
2013-11-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP